CNS Pharmaceuticals, Inc.

NASDAQ (USD): CNS Pharmaceuticals, Inc. (CNSP)

Last Price

1.22

Today's Change

-0.24 (16.43%)

Day's Change

1.20 - 1.41

Trading Volume

1,521,343

Overview

Market Cap

289,188

Shares Outstanding

237,039

Avg Volume

1,342,693

Avg Price (50 Days)

7.34

Avg Price (200 Days)

40.61

PE Ratio

0.00

EPS

-391.00

Earnings Announcement

12-Aug-2024

Previous Close

1.46

Open

1.32

Day's Range

1.2 - 1.4142

Year Range

1.2 - 137.5

Trading Volume

1,521,343

Price Change Highlight

1 Day Change

-16.44%

5 Day Change

-26.95%

1 Month Change

-77.37%

3 Month Change

-90.56%

6 Month Change

-97.95%

Ytd Change

-97.95%

1 Year Change

-98.91%

3 Year Change

-99.96%

5 Year Change

-99.98%

10 Year Change

-99.98%

Max Change

-99.98%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment